]>
IRCT201205262709N25 IRCT 2012-07-07 Gastrointestinal & Liver Disease Research Center (Firoozgar GILDRC) The comparison of the effect of eicosapentaenoic acid and docosahexaenoic acid in patients with helicobacter pylori infection The comparison of the effect of eicosapentaenoic acid and docosahexaenoic acid on lipoprotein profile & tumor necrosis factor-α in patients with helicobacter pylori Infection 2012-06-21 anticipated 105 Complete https://irct.ir/trial/2538 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment. N/A Helicobacter pylori. Intervention 1: intervention 1 group : daily 2 gr morEPA supplement during 12 weeks. Intervention 2: intervention 2 group : daily 2 gr morDHA supplement during 12 weeks. Intervention 3: control group : daily 2 gr MCT placebo during 12 weeks.
public Dr Farzad Shidfar
Number 60,The end of Alvand Street, Argentina square
Tehran Iran (Islamic Republic of) 1516846515 +98 21 8877 9118 farzadshidfar@yahoo.com School of Public Health of Tehran University of Medical Sciences scientific Dr Farzad Shidfar
Number 60,The end of Alvand street, Argentina square
Tehran Iran (Islamic Republic of) 1516846515 +98 21 8877 9118 farzadshidfar@yahoo.com School of Public Health of Tehran University of Medical Sciences Iran (Islamic Republic of) Inclusion criteria: positive helicobacter pylori test result; no history of pharmaceutical treatment for infection eradication; no gastric surgery; no history of peptic ulcer; no any disease that cause inflammation & increase of serum inflammatory markers level such as diabetes, CVD, respiratoryinflammations such as asthma,...; no consumption of any drug other than prescribed drugs during the study; no consumption of antibiotic or bismut during 2 months before the trial; no consumption of antioxidant supplements such as Se, Zn, beta-caroten,... at least 3 months before the trial; no consumption of omega-3 supplements at least 3 months before the trial; no smoking; BMI less than 30; age between 20-60 years old; leaning to cooperation Exclusion criteria: no leaning to continuing the cooperation; any change in type or dose of prescribed drugs; any change in daily diet or physical activity; consumption of any antioxidant supplement; consumption of less than 70% of supplements given to patients at the start of the study 20 years 60 years Both k27 Peptic ulcer, site unspecified Treatment - Drugs Treatment - Drugs Treatment - Drugs intervention 1 group : daily 2 gr morEPA supplement during 12 weeks intervention 2 group : daily 2 gr morDHA supplement during 12 weeks control group : daily 2 gr MCT placebo during 12 weeks Total cholesterol. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: enzymatic colorimetry. LDL-C. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: immunotorbidometry. HDL-C. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: immunotorbidometry. TG. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: colorimetry. TNF-alfa. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: enzymatic colorimetry. Gastrointestinal & Liver Disease Research Center (Firoozgar GILDRC) Approved 2010-10-10 School of Public Health of Tehran of University of Medical Sciences Number 60, Alvand Street, Argentina Square Tehran Iran (Islamic Republic of)